Literature DB >> 6249520

An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia.

C Lejeune-Lenain, F Cantraine, M Dufrasnes, F Prevot, R Wolter, J R Franckson.   

Abstract

A modified short ACTH test for the detection of heterozygote carriers of 21-hydroxylase deficiency (21-OHD) was applied to twenty-one controls and fourteen parents of children with 21-OHD. The following modifications were introduced: (1) Endogenous ACTH was suppressed by dexamethasone administration prior to the test, (2) Plasma 17-hydroxyprogesterone (17-OHP), cortisol (F), progesterone (P), corticosterone (B) and delta 4- androstenedione (A) were measured, (3) Variables studied were the ratio of plasma increments (delta) between precursors and end products, (4) Data were analysed by a step-wise discriminant analysis. Significant alterations in the metabolic pathway of F, B and A were demonstrated. The discriminant analysis showed that the addition of B pathway data did not improve the discrimination potency of the test performed on F pathway data. The combination of variates which provided the best discrimination was the logarithmic sum of delta 170HP/delta F at 15 and 30 min. It led to a 94% correct classification for normals and carriers.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6249520     DOI: 10.1111/j.1365-2265.1980.tb01372.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Partial 17, 20-desmolase and 17 alpha-hydroxylase deficiencies in a 16-year-old boy.

Authors:  D Bosson; R Wolter; M Toppet; J R Franckson; E de Peretti; M G Forest
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

Review 2.  Congenital adrenal hyperplasia: transition from chil dhood to adulthood.

Authors:  P W Speiser
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 5.467

3.  Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome.

Authors:  Beata Seeber; Elisabeth Morandell; Fabian Lunger; Ludwig Wildt; Hans Dieplinger
Journal:  Reprod Biol Endocrinol       Date:  2014-09-10       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.